Efficacy of pre-emptive kidney transplantation for adults with end-stage kidney disease

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

Presented the abstract " "
(Abstract co-author(s): )

Back

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.

E-Poster Format Requirements

PDF file
Layout: Portrait (vertical orientation)
One page only (Dim A4: 210 x 297mm or PPT)
E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
File Size: Maximum file size is 2 Megabytes (2 MB)
No hyperlinks, animated images, animations, and slide transitions
Language: English
Include your abstract number
E-posters can include QR codes, tables and photos

E-Poster

Abstract Title *

Efficacy of pre-emptive kidney transplantation for adults with end-stage kidney disease

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

The title will not be accepted if it exceeds 25 words.
Type in CAPITAL LETTERS.
Lowercase may be used for abbreviations only, for example, mRNA.

Co-author 1

Said Khamis saidkhamis1963@gmail.com Menoufia university Internal medicine and nephrology Cairo Egypt -

Co-author 2

Ahmed Rageb Ahmed.salim@med.menofia.edu.eg Menoufia university Internal medicine Shebin El kom Egypt -

Co-author 3

Tarek Fakher Tarekfakhreldienosman@gmail.com national institute of urology and nephrology Nephrology unit Cairo Egypt -

Co-author 4

Heba Kamal heba.abdallah@med.menofia.edu.eg Menoufia university Internal medicine department Shebin El kom Egypt *

Co-author 5

Gamal Elrashidy gamalnagah2020@gmail.com Nasser Institute Hospital for Research and Treatment Nephrology unit Cairo Egypt -

Co-author 6

Co-author 7

Co-author 8

Co-author 9

Co-author 10

Co-author 11

Co-author 12

Co-author 13

Co-author 14

Co-author 15

Introduction

The management of a failed kidney Tx-ESRD patients is complex and challenging. Although patients with Tx-ESRD would be expected to have better quality metrics during the transition back to dialysis, reports are controversial.

Methods

This study included 65 adult patients who were divided into 40 patients with native kidney failure, had no kidney transplantation previously (group I) and 25 transplanted patients with graft failure (group II). Patients were recruited and assessed for eligibility from the hemodialysis units at Nasser Institute Hospital, National Institute for Urology and Nephrology, and other hospitals.

Results

Mean duration baseline of ESRD care was 10.9 ± 5.1 months among patients in group I and 12.9 ± 4.8 months (P > 0.05). At baseline and after 6 months of starting dialysis, there was a significant increased serum creatinine and urea among group II compared to group I. There was a significant decreased hemoglobin and ferritin and a highly significant decreased calcium among patients in group II compared with group I. Meanwhile, there was a significant increased phosphorous among patients in group II to group I. Moreover, there was a significant decrease in albumin (after 6 months) among group II to group I.

Conclusion

Patients who return to dialysis after kidney allograft failure have poorer hemodialysis quality metrics than transplant-naïve dialysis incident patients in terms of anemia, hyperphosphatemia, hypocalcemia, hypercreatininemia, hyperuremia, and hypoalbuminemia.

Keywords: Hemodialysis, Hyperphosphatemia, Hyperuremia, Hypocalcemia, Native kidney failure end-stage renal disease, Transplant end-stage renal disease

Kewords